1 day Ago
HCW Biologics ( NASDAQ: HCWB ) has announced that its Board of Directors has approved a 1-for-40 reverse stock split of the Co.’s common stock, par value $0.0001, effective at on April 11, 2025 .
The Co.’s Common Stock will be traded on The.
